IBDEI06V ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3036,1,4,0)
 ;;=4^397.1
 ;;^UTILITY(U,$J,358.3,3036,1,5,0)
 ;;=5^Heart Dis Pulmon Valve
 ;;^UTILITY(U,$J,358.3,3036,2)
 ;;=^269587
 ;;^UTILITY(U,$J,358.3,3037,0)
 ;;=397.0^^33^271^42
 ;;^UTILITY(U,$J,358.3,3037,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3037,1,4,0)
 ;;=4^397.0
 ;;^UTILITY(U,$J,358.3,3037,1,5,0)
 ;;=5^Heart Dis Tricuspid Valve
 ;;^UTILITY(U,$J,358.3,3037,2)
 ;;=^35528
 ;;^UTILITY(U,$J,358.3,3038,0)
 ;;=424.90^^33^271^83
 ;;^UTILITY(U,$J,358.3,3038,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3038,1,4,0)
 ;;=4^424.90
 ;;^UTILITY(U,$J,358.3,3038,1,5,0)
 ;;=5^Valvular Heart Disease
 ;;^UTILITY(U,$J,358.3,3038,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,3039,0)
 ;;=V43.3^^33^271^77
 ;;^UTILITY(U,$J,358.3,3039,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3039,1,4,0)
 ;;=4^V43.3
 ;;^UTILITY(U,$J,358.3,3039,1,5,0)
 ;;=5^S/P Heart Valve Replacement
 ;;^UTILITY(U,$J,358.3,3039,2)
 ;;=^295440
 ;;^UTILITY(U,$J,358.3,3040,0)
 ;;=401.1^^33^271^58
 ;;^UTILITY(U,$J,358.3,3040,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3040,1,4,0)
 ;;=4^401.1
 ;;^UTILITY(U,$J,358.3,3040,1,5,0)
 ;;=5^Hypertension, Benign
 ;;^UTILITY(U,$J,358.3,3040,2)
 ;;=^269591
 ;;^UTILITY(U,$J,358.3,3041,0)
 ;;=796.2^^33^271^32
 ;;^UTILITY(U,$J,358.3,3041,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3041,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,3041,1,5,0)
 ;;=5^Elev BP w/o dx hypertension
 ;;^UTILITY(U,$J,358.3,3041,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,3042,0)
 ;;=402.10^^33^271^33
 ;;^UTILITY(U,$J,358.3,3042,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3042,1,4,0)
 ;;=4^402.10
 ;;^UTILITY(U,$J,358.3,3042,1,5,0)
 ;;=5^HTN w/ Heart Involvement
 ;;^UTILITY(U,$J,358.3,3042,2)
 ;;=^269598
 ;;^UTILITY(U,$J,358.3,3043,0)
 ;;=402.11^^33^271^34
 ;;^UTILITY(U,$J,358.3,3043,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3043,1,4,0)
 ;;=4^402.11
 ;;^UTILITY(U,$J,358.3,3043,1,5,0)
 ;;=5^HTN with CHF
 ;;^UTILITY(U,$J,358.3,3043,2)
 ;;=HTN with CHF^269599
 ;;^UTILITY(U,$J,358.3,3044,0)
 ;;=403.11^^33^271^39
 ;;^UTILITY(U,$J,358.3,3044,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3044,1,4,0)
 ;;=4^403.11
 ;;^UTILITY(U,$J,358.3,3044,1,5,0)
 ;;=5^HTN with Renal Failure
 ;;^UTILITY(U,$J,358.3,3044,2)
 ;;=^269608
 ;;^UTILITY(U,$J,358.3,3045,0)
 ;;=404.10^^33^271^37
 ;;^UTILITY(U,$J,358.3,3045,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3045,1,4,0)
 ;;=4^404.10
 ;;^UTILITY(U,$J,358.3,3045,1,5,0)
 ;;=5^HTN with Heart & Renal Involvement
 ;;^UTILITY(U,$J,358.3,3045,2)
 ;;=^269618
 ;;^UTILITY(U,$J,358.3,3046,0)
 ;;=404.11^^33^271^35
 ;;^UTILITY(U,$J,358.3,3046,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3046,1,4,0)
 ;;=4^404.11
 ;;^UTILITY(U,$J,358.3,3046,1,5,0)
 ;;=5^HTN with CHF & Renal Involvement
 ;;^UTILITY(U,$J,358.3,3046,2)
 ;;=^269619
 ;;^UTILITY(U,$J,358.3,3047,0)
 ;;=404.12^^33^271^38
 ;;^UTILITY(U,$J,358.3,3047,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3047,1,4,0)
 ;;=4^404.12
 ;;^UTILITY(U,$J,358.3,3047,1,5,0)
 ;;=5^HTN with Heart Involvement & Renal Failure
 ;;^UTILITY(U,$J,358.3,3047,2)
 ;;=^269620
 ;;^UTILITY(U,$J,358.3,3048,0)
 ;;=404.13^^33^271^36
 ;;^UTILITY(U,$J,358.3,3048,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3048,1,4,0)
 ;;=4^404.13
 ;;^UTILITY(U,$J,358.3,3048,1,5,0)
 ;;=5^HTN with CHF & Renal failure
 ;;^UTILITY(U,$J,358.3,3048,2)
 ;;=^269621
 ;;^UTILITY(U,$J,358.3,3049,0)
 ;;=401.9^^33^271^59
 ;;^UTILITY(U,$J,358.3,3049,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3049,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,3049,1,5,0)
 ;;=5^Hypertension, Essential
 ;;^UTILITY(U,$J,358.3,3049,2)
 ;;=^186630
